HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dual antiplatelet therapy in the secondary prevention of atherothrombosis: need for new therapeutic approaches.

AuthorsBrigitte Sabatier, Ludovic Trinquart, Joseph Emmerich
JournalArchives of cardiovascular diseases (Arch Cardiovasc Dis) Vol. 103 Issue 10 Pg. 497-501 (Oct 2010) ISSN: 1875-2128 [Electronic] Netherlands
PMID21130962 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
Topics
  • Atherosclerosis (prevention & control)
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Fibrinolytic Agents (adverse effects, therapeutic use)
  • Hemorrhage (chemically induced)
  • Humans
  • Platelet Aggregation Inhibitors (adverse effects, therapeutic use)
  • Risk Assessment
  • Risk Factors
  • Secondary Prevention
  • Thrombosis (prevention & control)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: